Leukemia Arising out of Paroxysmal Nocturnal Hemoglobinuria

References

• Gull W. W. A case of intermittent haematinuria. Guys Hospital Report 1866; 13: 381–392
   Google Scholar
• Strübing P. Paroxysmal haemoglobinurie. Deutsche Medizinische Wochenschrift 1882; 8: 1–17
   Google Scholar
• Hijmans van den Bergh A. A. Ictère hémolytique avec crises hémoglobinuiques. Fragilité globulaire. Revue de Médecine (Paris) 1911; 31: 63–39
   Google Scholar
• Ham T. H. Chronic hemolytic anemia with paroxysmal nocturnal hemoglobinuria. Study of the mechanism of hemolysis in relation to acid‐base equilibrium. New England Journal of Medicine 1937; 217: 915–917
   Google Scholar
• Ham T. H. Studies on destruction of red blood cells. I. Chronic hemolytic anemia with paroxysmal nocturnal hemoglobinuria: an investigation of the mechanism of hemolysis, with observations on five cases. Archives of Internal Medicine 1939; 64: 1271–1305
   Google Scholar
• Ham T. H., Dingle J. H. Studies on destruction of red blood cells. II. Chronic hemolytic anemia with paroxysmal nocturnal hemoglobinuria: certain immunological aspects of the hemolytic mechanism with special reference to serum complement. Journal of Clinical Investigation 1939; 18: 1271–1305
   Google Scholar
• Oni S. B., Osunkoya B. O., Luzzatto L. Paroxysmal nocturnal hemoglobinuria: Evidence for monoclonal origin of abnormal red cells. Blood 1970; 36: 145–152
   PubMed Web of Science ®Google Scholar
• Nicholson‐Weller A., March J. P., Rosenfeld S. I., Austen K. F. Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factor. Proceedings of the National Academy of Sciences (USA) 1983; 80: 5430–5434
   PubMed Web of Science ®Google Scholar
• Pangburn M. K., Schreiber R. D., Muller‐Eberhard H. J. Deficiency of an erythrocyte membrane protein with complement regulatory activity in paroxysmal nocturnal hemoglobinuria. Proceedings of the National Academy of Sciences (USA) 1983; 80: 5430–5434
   PubMed Web of Science ®Google Scholar
• Kinoshita T., Medof M. E., Silber R., Nussenszweig V. Distribution of decay‐accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria. Journal of Experimental Medicine 1985; 162: 75–92
   PubMed Web of Science ®Google Scholar
• Holguin M. H., Fredrick L. R., Bernshaw N. J., Wilcox L. A., Parker C. J. Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria. Journal of Clinical Investigation 1989; 84: 7–17
   PubMed Web of Science ®Google Scholar
• Whitlow M. B., Iida K., Stefanova I., Bernard A., Nussenzweig V. H19, a surface membrane molecule involved in T‐cell activation, inhibits channel formation by human complement. Cellular Immunology 1990; 126: 176–184
   PubMed Web of Science ®Google Scholar
• Okada N., Harada R., Taguchi R., Okada H. Complete deficiency of 20 KDa homologous restriction factor (HRF20) and restoration with purified HRF20. Biochemical and Biophysical Research Communications 1989; 164: 468–473
   PubMed Web of Science ®Google Scholar
• Medof M. E., Kinoshita T., Nussenzweig V. Inhibition of complement activation on the surface of cells after incorporation of decay‐accelerating factor (DAF) into their membranes. Journal of Experimental Medicine 1984; 160: 1558–1578
   PubMed Web of Science ®Google Scholar
• Englund P. T. The structure and biosynthesis of glycosyl phosphatidylinositol protein anchors. Annual Review of Biochemistry 1993; 62: 121–138
   PubMed Web of Science ®Google Scholar
• Stevens V. L. Biosynthesis of glycosylphosphatidylinositol membrane anchors. Biochemical Journal 1995; 310: 361–370
   PubMed Web of Science ®Google Scholar
• Sugiyama E., DeGasperi R., Urakaze M., Chang H. M., Thomas L. J., Hyman R., Warren C. D., Yeh E. T. Identification of defects in glycosylphosphatidylinositol anchor biosynthesis in the Thy‐1 expression mutants. Journal of Biological Chemistry 1991; 266: 12119–12122
   PubMed Web of Science ®Google Scholar
• Urakaze M., Kamitani T., DeGasperi R., Sugiyama E., Chang H. M., Warren C. D., Yeh E. T. Identification of a missing link in glycosylphosphatidylinositol anchor biosynthesis in mammalian cells. Journal of Biological Chemistry 1992; 267: 6459–6462
   PubMed Web of Science ®Google Scholar
• Puoti A., Desponds C., Fankhauser C., Conzelmann A. Characterization of a glycophospholipid intermediate in the biosynthesis of glycophosphatidylinositol anchors accumulating in the Thy‐1‐negative lymphoma line SIA‐B. Journal of Biological Chemistry 1991; 266: 21051–21059
   PubMed Web of Science ®Google Scholar
• Hirose S., Prince G. M., Sevlever D., Ravi L., Rosenberry T. L., Ueda E., Medof M. E. Characterization of putative glycoinositol phospholipid anchor precursors in mammalian cells. Localization of phosphoethanolamine. Journal of Biological Chemistry 1992; 267: 16968–16974
   PubMed Web of Science ®Google Scholar
• Armstrong C., Schubert J., Ueda E., Knez J. J., Gelperin D., Hirose S., Silber R., Hollan S., Schmidt R. E., Medof M. E. Affected paroxysmal nocturnal hemoglobinuria T lymphocytes harbor a common defect in assembly of N‐acetyl‐D‐glucosamine inositol phospholipid corresponding to that in class A Thy‐1− murine lymphoma mutants. Journal of Biological Chemistry 1992; 267: 25347–25351
   PubMed Web of Science ®Google Scholar
• Takahashi M., Takeda J., Hirose S., Hyman R., Inoue N., Miyata T., Ueda E., Kitani T., Medof M. E., Kinoshita T. Deficient biosynthesis of N‐acetylglucosaminyl‐phosphatidylinositol, the first intermediate of glycosyl phosphatidylinositol anchor biosynthesis, in cell lines established from patients with paroxysmal nocturnal hemoglobinuria. Journal of Experimental Medicine 1993; 177: 517–521
   PubMed Web of Science ®Google Scholar
• Takeda J., Miyata T., Kawagoe K., Iida Y., Endo Y., Fujita T., Takahashi M., Kitani T., Kinoshita T. Deficiency of the GPI anchor caused by a somatic mutation of the PIG‐A gene in paroxysmal nocturnal hemoglobinuria. Cell 1993; 73: 703–711
   PubMed Web of Science ®Google Scholar
• Leidich S., Orlean P. Gpil, a S. cerevisiae protein that participates in the first step of GPI anchor synthesis. Journal of Biological Chemistry 1996; 271: 27829–27837
   PubMed Web of Science ®Google Scholar
• Bessler M., Mason P., Hillmen P., Luzzatto L. Somatic mutations and cellular selection in paroxysmal nocturnal haemoglobinuria. Lancet 1994; 343: 951–953
   PubMed Web of Science ®Google Scholar
• Bessler M., Mason P. J., Hillmen P., Miyata T., Yamada N., Takeda J., Luzzatto L., Kinoshita T. Paroxysmal nocturnal haemoglobinuria (PNH) is caused by somatic mutations in the PIG‐A gene. The EMBO Journal 1994; 13: 110–117
   PubMed Web of Science ®Google Scholar
• Bessler M., Mason P. J., Hillmen P., Luzzatto L. Mutations in the PIG‐A gene causing partial deficiency of GPI‐linked surface proteins (PNH II) in patients with paroxysmal nocturnal haemoglobinuria. British Journal of Haematology 1994; 87: 863–866
   PubMed Web of Science ®Google Scholar
• Miyata T., Yamada N., Iida Y., Nishimura J., Takeda J., Kitani T., Kinoshita T. Abnormalities of PIG‐A transcripts in granulocytes from patients with paroxysmal nocturnal hemoglobinuria. New England Journal of Medicine 1994; 330: 249–255
   PubMed Web of Science ®Google Scholar
• Ware R. E., Rosse W. F., Howard T. A. Mutations within the Piga gene in patients with paroxysmal nocturnal hemoglobinuria. Blood 1994; 83: 2418–2422
   PubMed Web of Science ®Google Scholar
• Nafa K., Mason P. J., Hillman P., Luzzatto L., Bessier M. Mutations in the PIG‐A gene causing paroxysmal nocturnal hemoglobinuria are mainly of the frameshift type. Blood 1995; 86: 4650–4655
   PubMed Web of Science ®Google Scholar
• Nagarajan S., Brodsky R. A., Young N. S., Medof M. E. Genetic defects underlying paroxysmal nocturnal hemoglobinuria that arises out of aplastic anemia. Blood 1995; 86: 4656–4661
   PubMed Web of Science ®Google Scholar
• Yamada N., Miyata T., Maeda K., Kenji M., Kitani T., Takeda J., Kinoshita T. Somatic mutations of the PIG‐A gene found in Japanese patients with paroxysmal nocturnal hemoglobinuria. Blood 1995; 85: 885–892
   PubMed Web of Science ®Google Scholar
• Ostendorf T., Nischan C., Schubert J., Grussenmeyer T., Scholz C., Zielinska‐Skowronek M., Schmidt R. E. Heterogeneous PIG‐A mutation in different cell lineages in paroxysmal nocturnal hemoglobinuria. Blood 1995; 85: 1640–1646
   PubMed Web of Science ®Google Scholar
• Pramoonjago B. P., Wanachiwanawin W., Chinprasertsak S., Pattanapanayasat K., Takeda J., Kinoshita T. Somatic mutation of PIG‐A in Thai patients with paroxysmal nocturnal hemoglobinuria. Blood 1995; 86: 1736–1739
   PubMed Web of Science ®Google Scholar
• Stafford H. A., Nagarajan S., Weinberg J. B., Medof M. E. PIG‐A, DAF and proto‐oncogene expression in paroxysmal nocturnal haemoglobinuria‐associated acute myelogenous leukaemia blasts. British Journal of Haematology 1995; 89: 72–78
   PubMed Web of Science ®Google Scholar
• Endo M., Ware R. E., Vreeke T. M., Singh S. P., Howard T. A., Tomita A., Holguin M. H., Parker C. J. Molecular basis of the heterogeneity of expression of glycosyl phosphatidylinositol anchored proteins in paroxysmal nocturnal hemoglobinuria. Blood 1996; 87: 2546–2557
   PubMed Web of Science ®Google Scholar
• Savoia A., Ianzauo L., Lunardi C., DeSandre G., Carontenuto M., Musto P., Zelante L. Identification of three novel mutations in the PIG‐A gene in paroxysmal nocturnal hemoglobinuria (PNH) patients. Human Genetics 1996; 97: 45–48
   PubMed Web of Science ®Google Scholar
• Lin L. ‐I., Liu C. ‐H., Chen Y. ‐C., Shen M. ‐C., Wang C. ‐H., Huang Y. ‐L. PIG‐A gene mutations in four Taiwanese patients with paroxysmal nocturnal haemoglobinuria following aplastic anaemia. British Journal of Haematology 1997; 97: 286–292, 1997
   PubMed Web of Science ®Google Scholar
• Nishimura J., Inoue N., Wada H., Ueda E., Pramoonjago P., Hirota T., Machii T., Kageyama T., Kanamaru A., Takeda J., Kinoshita T., Kitani T. A patient with paroxysmal nocturnal hemaglobinuria bearing four independent PIG‐A mutant clones. Blood 1997; 89: 3470–3476
   PubMed Web of Science ®Google Scholar
• Rollinson S., Richards S., Norfolk D., Bibi K., Morgan G., Hillmen P. Both paroxysmal nocturnal hemoglobinuria (PNH) type II cells and PNH type III cells can arise from different point mutations involving the same codon of the PIG‐A gene. Blood 1997; 89: 1039–3071
   Google Scholar
• Zheng P., Liu E. K., Chang C. N. Clinical analysis of 169 cases of paroxysmal nocturnal hemoglobinuria. Blood 1987; 70(Suppl 1)117a
   Google Scholar
• Lee G. R. Wintrobe's Clinical Hematology9th edition. Lea and Febiger, Philadelphia 1993
   Google Scholar
• Ploug M., Plesner T., Ronne E., Ellis V., Hoyer Hansen G., Hansen N. E., Dano K. The receptor for urokinase‐type plasminogen activator is deficient on peripheral blood leukocytes in patients with paroxysmal nocturnal haemoglobinuria. Blood 1992; 79: 1447–1455
   PubMed Web of Science ®Google Scholar
• Dacie J. V., Lewis S. M. Paroxysmal nocturnal hemoglobinuria, clinical manifestations, hematology and nature of the disease. Ser. Haematol. 1972; 5: 3–23
   PubMedGoogle Scholar
• Rosse W. F. Paroxysmal nocturnal hemoglobinuria—present status and future prospects. Western Journal of Medicine 1980; 132: 219–228
   PubMedGoogle Scholar
• Valla D., Dhumeaux D., Babany G., Hillon P., Rueff B., Rochant H., Benhamou J. P. Hepatic vein thrombosis in paroxysmal nocturnal hemoglobinuria. A spectrum from asymptomatic occlusion of hepatic venules to fatal Budd‐Chiari syndrome. Gastroenterology 1987; 93: 569–575
   PubMed Web of Science ®Google Scholar
• Dacie J. V., Lewis S. M. Paroxysmal nocturnal hemoglobinuria: Variation in clinical severity and association with bone marrow hypoplasia. British Journal of Haematology 1961; 7: 442–457
   PubMed Web of Science ®Google Scholar
• Clark D. A., Butler S. A., Braren V., Hartmann R. C., Jenkins D. E., Jr. The kidneys in paroxysmal nocturnal hemoglobinuria. Blood 1981; 57: 83–89
   PubMed Web of Science ®Google Scholar
• Crosby W. H. Paroxysmal nocturnal hemoglobinuria. Relation of the clinical manifestations to the underlying pathogenic mechanisms. Blood 1953; 8: 769–812
   PubMed Web of Science ®Google Scholar
• Charache S. Prolonged survival in paroxysmal nocturnal hemoglobinuria. Blood 1967; 33: 877–883
   Web of Science ®Google Scholar
• Yomtovian R., Prince G. M., Medof M. E. The molecular basis for paroxysmal nocturnal hemogloninuria. Transfusion 1993; 33: 852–873
   PubMed Web of Science ®Google Scholar
• Nicholson‐Weller A., Wang C. E. Structure and function of decay accelerating factor CD55. Journal of Laboratory and Clinical Medicine 1994; 123: 485–491
   PubMed Web of Science ®Google Scholar
• Hirose S., Knez J. J., Medof M. E. Mammalian glycosylphosphatidylinositol‐anchored proteins and intracellular precursors. Methods in Enzymology 1995; 250: 582–614
   PubMed Web of Science ®Google Scholar
• Lublin D. M., Mallison G., Poole J., Reid M. E., Thompson E. S., Ferdman B. R., Telen M. J., Anstee D. J., Tanner M. J. A. Molecular basis of reduced or absent expression of decay‐accelerating factor in Cromer blood group. Blood 1994; 84: 1276–1287
   PubMed Web of Science ®Google Scholar
• Yamashina M., Ueda E., Kinoshita T., Takami T., Ojima A., Ono H., Tanaka H., Kondo N., Orii T., Okada N., Okada H., Inoue K., Kitani T. Inherited complete deficiency of 20‐kilodalton homologous restriction factor (CD59) as a cause of paroxysmal nocturnal hemoglobinuria. New England Journal of Medicine 1990; 323: 1184–1189
   PubMed Web of Science ®Google Scholar
• Motoyama N., Okada N., Yamashina M., Okada H. Paroxysmal nocturnal hemoglobinuria due to hereditary nucleotide deletion of HRF20 (CD59) gene. European Journal of Immunology 1992; 22: 2669–2673
   PubMed Web of Science ®Google Scholar
• Seya T., Tejima H., Fukudu H., Hara T., Matsumoto M., Hatanaka M., Sugita Y., Masaoka T. Acute promeylocytic leukemia with CD59 deficiency. Leukemia Research 1993; 17: 895–896
   PubMed Web of Science ®Google Scholar
• Endo M., Ware R. E., Vreeke T. M., Howard T. A., Parker C. J. Identification and characterization of an inherited mutation of PIG‐A in a patient with paroxysmal nocturnal hemoglobinuria. British Journal of Haematology 1996; 93: 590–593
   PubMed Web of Science ®Google Scholar
• Hillman P., Lewis S. M., Bessler M., Luzzatto L., Dacie J. V. Natural history of paroxysmal nocturnal hemoglobinuria. New England Journal of Medicine 1995; 333: 1253–1258
   PubMed Web of Science ®Google Scholar
• Ariel I., Weiler‐Ravell D., Stalnikowicz R. Preleukemia in acute lymphoblastic leukemia. Acta Haematologica 1981; 66: 50–52
   PubMed Web of Science ®Google Scholar
• Katahira J., Aoyama M., Oshimi K., Mizoguchi H., Okada M. Paroxysmal nocturnal hemoglobinuria terminating in TdT‐positive acute leukemia. American Journal of Hematology 1983; 14: 79–87
   PubMed Web of Science ®Google Scholar
• Omura G. A. Coexistence of paroxysmal nocturnal hemoglobinuria and chronic lymphocytic leukemia. American Journal of Hematology 1981; 11: 439–441
   PubMed Web of Science ®Google Scholar
• Hill R. S., Catovsky D., Lewis S. M. Paroxysmal nocturnal haemoglobinuria‐like red cell abnormality in patient with lymphoproliferative disease. British Medical Journal 1972; 4: 649–650
   PubMed Web of Science ®Google Scholar
• Watson D. K., Barlow A. M., Hewer E. M. Paroxysmal nocturnal haemoglobinuria‐like defect in red cells in chronic lymphatic leukaemia. British Medical Journal 1976; 2: 1484
   PubMed Web of Science ®Google Scholar
• Ligorsky R. D., Schaffner S., Oliver J., Oliver D., Lavine D. Unusual association between non‐Hodgkin's malignant lymphoma and a PNH‐like defect in the red cell. American Journal of Medicine 1994; 96: 395–396
   PubMed Web of Science ®Google Scholar
• Christou T., Subramanian S., Fung C. Paroxysmal nocturnal hemoglobinuria preceding malignant lymphoma. Archives of Internal Medicine 1987; 147: 377–378
   PubMed Web of Science ®Google Scholar
• Forman K., Sokol R. J., Hewitt S., Stamps B. K. Paroxysmal nocturnal haemoglobinuria. A clinico‐pathological study of 26 cases. Acta Haematologica 1984; 71: 217–226
   PubMed Web of Science ®Google Scholar
• Okada M., Katahira J., Mizoguchi H. Missing Y clones in a patient with lymphoblastic leukemia and paroxysmal nocturnal hemoglobinuria. Cancer Genetics and Cytogenetics 1982; 7: 307–311
   PubMed Web of Science ®Google Scholar
• DeGramont A., Debray J. Hemoglobinurie paroxystique nocturne: synthese et reflexions a pastir d'une serie francophone de 151 patients. Revue de Medecine Interne 1985; 6: 477–483
   PubMed Web of Science ®Google Scholar
• Kaufmann R. W., Schechter G. P., McFarland W. Paroxysmal nocturnal hemoglobinuria terminating in acute granulocytic leukemia. Blood 1969; 33: 287–291
   PubMed Web of Science ®Google Scholar
• Krause J. R. Paroxysmal nocturnal hemoglobinuria and acute nonlymphocytic leukemia. A report of three cases exhibiting different cytologic types. Cancer 1983; 51: 2078–2082
   PubMed Web of Science ®Google Scholar
• Sultan C., Cosson A., Priolet G., Dreyfus B. Sideroblastic anemia complicating aplastic anemia. Nouvelle Presse Medicate 1972; 1: 443–445
   PubMedGoogle Scholar
• Holden D., Lichtman H. Paroxysmal nocturnal hemoglobinuria with acute leukemia. Blood 1969; 33: 283–286
   PubMed Web of Science ®Google Scholar
• Kawano F., Chosa M., Matsuoka M., Oyamada N., Takatsuki K. Paroxysmal nocturnal hemoglobinuria: termination in acute monocytic leukemia and reappearance after chemotherapy with N4‐palmitoyl‐1‐beta‐D‐arabinofuranosyl‐cytosine (PL‐AC) and vincristine. Japanese Journal of Clinical Oncology 1987; 17: 123–128
   PubMed Web of Science ®Google Scholar
• Aymard J. P., Buisine J., Gregoire M. J., Janot C., Streiff F. Refractory anaemia with excess of blasts as a terminal evolution of paroxysmal nocturnal haemoglobinuria: A case report with chromosomal analysis. Acta Haematologica 1985; 74: 181–183
   PubMed Web of Science ®Google Scholar
• Jenkins D. E., Jr., Hartmann R. C. Paroxysmal nocturnal hemoglobinuria terminating in acute myeloblastic leukemia. Blood 1969; 33: 274–282
   PubMed Web of Science ®Google Scholar
• Parlier V., Tiainen M., Beris P., Miescher P. A., Knuutila S., Jotterand‐Bellomo M. Trisomy 8 detection in granulomonocytic, erythrocytic and megakaryocytic lineages by chromosomal in situ suppression hybridization in a case of refractory anaemia with ringed sideroblasts complicating the course of paroxysmal nocturnal haemoglobinuria. British Journal of Haematology 1992; 81: 296–304
   PubMed Web of Science ®Google Scholar
• Seaman A. J. Sequels to chloramphenicol aplastic anemia: acute leukemia and paroxysmal nocturnal hemoglobinuria. Northwest Medicine 1969; 68: 831–834
   PubMedGoogle Scholar
• Longo L., Bessler M., Beris P., Swirsky D., Luzzatto L. Myelodysplasia in a patient with pre‐existing paroxysmal nocturnal haemoglobinuria: a clonal disease originating from within a clonal disease. British Journal of Haematology 1994; 87: 401–403
   PubMed Web of Science ®Google Scholar
• Evans D. I. Paroxysmal nocturnal haemoglobinuria and leukemia. British Medical Journal 1969; 4: 300–301
   PubMed Web of Science ®Google Scholar
• Luzzatto L., Familusi J. B., Williams C. K., Junaid T. A., Rotoli B., Alfinito F. The PNH abnormality in myeloproliferative disorders: association of PNH and acute erythremic myelosis in two children. Haematologica 1979; 64: 13–30
   PubMedGoogle Scholar
• Graham D. L., Gastineau D. A. Paroxysmal nocturnal hemoglobinuria as a marker for clonal myelopathy. American Journal of Medicine 1992; 93: 671–674
   PubMed Web of Science ®Google Scholar
• Wasi P., Kruatrachue M., Na‐Nakorn S. Aplastic anemia‐paroxysmal nocturnal hemoglobinuria syndrome‐acute leukemia in the same patient. The first record of such occurrence. Journal of the Medical Association of Thailand 1970; 53: 656–663
   PubMedGoogle Scholar
• Teyssier J. R., Pigeon F., Behar C., Pignon B., Blaise A. M. Chromosomal subclonal evolution in paroxysmal nocturnal hemoglobinuria evolving into acute megakaryoblastic leukemia. Cancer Genetics and Cytogenetics 1987; 25: 259–264
   PubMed Web of Science ®Google Scholar
• Socié G. Could aplastic anaemia be considered a pre‐pre‐leukaemic disorder?. European Journal of Haematology. Supplementum. 1996; 60: 60–63
   PubMedGoogle Scholar
• Hiroshige Y., Matsumoto N., Harima K., Miwa S., Kamei T., Ishihara T. An autopsy case of aplastic anemia‐PNH syndrome terminated in acute granulocytic leukemia. Nippon Ketsueki Gakkai Zasshi 1977; 40: 16–23
   PubMedGoogle Scholar
• Fujise K., Murata M., Norihashi T., Nagamori S., Yamada H., Fujisama R., Kamada H., Kuraishi Y. A case of acute myelogenous leukemia ensued from PNH. Japanese Clinical Hematology 1978; 20: 37
   Google Scholar
• Endo Y., Kawatani H., Nakahata T. Y. W., Komiyama J., Akabane T. A case of aplastic anemia‐PNH syndrome terminated in acute myelogenous leukemia with 14 trisomy. Japanese Journal of Clinical Hematology 1978; 20: 38
   Google Scholar
• Horie K. Periodic acid‐Schiff reaction of erythroblasts in erythemic myelosis and neutrophil alkaline phos‐phatase activity in paroxysmal nocturnal hemoglobinuria Rinsho Byori. Japanese Journal of Clinical Pathology 1969; 17: 42–43
   PubMedGoogle Scholar
• Tso S. C., Chan T. K. Paroxysmal nocturnal haemoglobinuria and chronic myeloid leukaemia in the same patient. Scandinavian Journal of Haematology 1973; 10: 384–389
   PubMedGoogle Scholar
• Carmel R., Coltman C., Jr, Yatteau R. F., Costanzi J. J. Association of paroxysmal nocturnal hemoglobinuria with erythroleukemia. New England Journal of Medicine 1970; 283: 1329–1331
   PubMed Web of Science ®Google Scholar
• Mehta B. C., Bhatt P. D., Iyer P., Golwala A. F., Patel J. C. Paroxysmal nocturnal hemoglobinuria in a case of chronic myeloid leukemia. Indian Journal of Medical Sciences 1973; 27: 249–252
   PubMedGoogle Scholar
• DeGramont A. 1982, quoted in Aymard, J. P. 1985, Paris
   Google Scholar
• Tsevrenis H., Pouggouras P., Simos A., Contopoulou I., Papazacharias A., Dariotis A. Course of paroxysmal nocturnal hemoglobinuria, Marchiafava‐Micheli disease, in acute leucosis. Nouvelle Revue Française d'Hematologie 1970; 10: 274–277
   PubMedGoogle Scholar
• Shaw M. T., Bottomley S. S., Bottomley R. H., Hussein K. K. The relationship of erythromonocytic leukemia to other myeloproliferative disorders. American Journal of Medicine 1973; 55: 542–548
   PubMed Web of Science ®Google Scholar
• Hellriegel K. P., Fohlmeister I., Schaefer H. E. Aplastic anemia terminating in leukemia. Haematologia und Bluttransfusion 1979; 24: 47–51
   PubMedGoogle Scholar
• Shimano S., Omine M., Yashiro K., Tsuchiya J., Maekawa T. A case of paroxysmal nocturnal hemoglobinuria terminating in erythroleukemia after 22 years' observation. Nippon Ketsueki Gakkai Zasshi 1983; 46: 30–34
   PubMedGoogle Scholar
• Kudou H., Nagasawa T., Yoda T., Sakurai T., Kawada K., Onozawa K., Nakajima T., Kashiwagi H., Nomura T. A case of paroxysmal nocturnal hemoglobinuria associated with the clinical features of erythroleukemia. Acta Haematologica Japonica 1974; 15: 1066, abstract; quoted in Shimano '1083
   Google Scholar
• Agarwal M. B., Mehta B. C. Paroxysmal nocturnal hemoglobinuria. A report of 20 cases. Journal of Postgraduate Medicine 1981; 27: 231–234
   PubMedGoogle Scholar
• Huang W. X., Zhang Z. N., Li Y. N., Zhang A. Clinical analysis of 128 cases of paroxysmal nocturnal hemoglobinuria. Chinese Journal of Internal Medicine 1984; 23: 359–361
   PubMedGoogle Scholar
• Devine D., Gluck W. L., Rosse W. F., Weinberg J. B. Acute myeloblastic leukemia in paroxysmal nocturnal hemoglobinuria. Evidence of evolution from the abnormal paroxysmal nocturnal hemoglobinuria clone. Journal of Clinical Investigation 1987; 79: 314–317
   PubMed Web of Science ®Google Scholar
• Cowall D. E., Pasquale D. N., Dekker P. Paroxysmal nocturnal hemoglobinuria terminating as erythroleukemia. Cancer 1979; 43: 1914–1916
   PubMed Web of Science ®Google Scholar
• Tichelli A., Gratwohl A., Wursch A., Nissen C., Speck B. Late haematological complications in severe aplastic anemia. British Journal of Haematology 1988; 69: 413–418
   PubMed Web of Science ®Google Scholar
• Fujioka S. Paroxysmal nocturnal haemoglobinuria in Japan: clinical analysis of the 133 cases Rinsho Ketsueki. Japanese Journal of Clinical Hematology 1979; 20: 700–708
   PubMedGoogle Scholar
• Fujioka S., Asai T. Prognostic features of paroxysmal nocturnal hemoglobinuria in Japan. Acta Haematologica Japonica 1989; 52: 1386–1394
   Web of Science ®Google Scholar
• Garcia Triana Y. Appearance of different panmyel‐opathies in the same patient. Sangre 1992; 37: 151–152
   PubMedGoogle Scholar
• Kiga Y., Umeda M., Kanako H., Hirahata T., Ishikawa I., Takatsuki Y., Mugitani H., Tsukahara T., Shirai T., Ishihara K. A case of paroxysmal nocturnal hemoglobinuria which occurred during the course of erythroleukemia Rinsho Ketsueki. Japanese Journal of Clinical Hematology 1980; 21: 1193–1200
   PubMedGoogle Scholar
• Hisatake K., Wada S., Iyota K., Tanioka F., Yamamoto M., Numata Y., Yamano T. Chronic myelomonocytic leukemia (CMMoL) with systemic lymph node swelling and paroxysmal nocturnal hemoglobinuria (PNH)‐like complication Rinsho Ketsueki. Japanese Journal of Clinical Hematology 1989; 30: 1963–1968
   PubMedGoogle Scholar
• Nakahata J. ‐I., Takahashi M., Fuse I., Nakamori Y., Nomoto N., Saitoh H., Tatewaki W., Imanari A., Takeshige T., Koike T., Shibata A. Paroxysmal nocturnal hemoglobinuria with myelofibrosis: progression to acute myeloblastic leukemia. Leukemia and Lymphoma 1993; 12: 137–142
   PubMed Web of Science ®Google Scholar
• Shichishima T., Terasawa T., Hashimoto C., Ohto H., Takahashi M., Shibata A., Maruyama Y. Discordant and heterogeneous expression of GPI‐anchored membrane proteins on leukemic cells in a patient with paroxysmal nocturnal hemoglobinuria. Blood 1993; 81: 1855–1862
   PubMed Web of Science ®Google Scholar
• Rosse W. F. Paroxysmal nocturnal hemoglobinuria. Hematology. Basic Principles and Practice, R. Hoffman, E. J. Benz, S. J. Shattil, B. Furie, H. J. Cohen, L. E. Silberstein. Churchill Livingstone, New York 1995
   Google Scholar
• Tudela M., Jarque I., Perez‐Sirvent M. L., Palau J., Sanz M. A. Clinical profile and course of paroxysmal nocturnal hemoglobinuria. Sangre 1993; 38: 301–307
   PubMedGoogle Scholar
• Socié G., Mary J. Y., de Gramont A., Gluckman E. Long term follow‐up and prognostic factors in paroxysmal nocturnal hemoglobinuria (PNH): a study of 203 cases by the French Society of Hematology. Blood 1995; 86: 130a
   Google Scholar
• Tsuchimoto T., Ishii Y., Uchino H., Inoue S. Paroxysmal nocturnal haemoglobinuria with chromosome abnormalities: possible preleukaemia. Lancet 1970; 1: 617–618
   PubMed Web of Science ®Google Scholar
• Maciejewski J. P., Sloand E. M., Sato T., Anderson S., Young N. S. Impaired hematopoiesis in paroxysmal nocturnal hemaglobinuria/aplastic anemia is not associated with a selective proliferative defect in the glyco‐sylphosphatidylinositol‐anchored protein‐deficient clone. Blood 1997; 89: 1179–1181
   Google Scholar
• Yamada K., Furusawa S. Preferential involvement of chromosomes No. 8 and No. 21 in acute leukemia and preleukemia. Blood 1976; 47: 679–686
   PubMed Web of Science ®Google Scholar
• Dameshek W., Fudenberg H. Paroxysmal nocturnal hemoglobinuria. Atypical manifestations suggesting an immunologic disease. Archives of Internal Medicine 1957; 99: 202–208
   Web of Science ®Google Scholar
• Hansen N. E., Killmann S. A. Paroxysmal nocturnal haemoglobinuria. A clinical study. Acta Medica Scandinavica 1968; 184: 525–541
   PubMed Web of Science ®Google Scholar
• Hansen N. E., Killmann S. A. Paroxysmal nocturnal hemoglobinuria in myelofibrosis. Blood 1970; 36: 428–431
   PubMed Web of Science ®Google Scholar
• Ohyashiki K., Ohyashiki J. H., Ryan D. H., Miller K. B., Ito H., Sandberg A. A. Translocation between chromosomes 7 and 11 in nonlymphocytic neoplasia. Cancer Genetics and Cytogenetics 1987; 26: 191–197
   PubMed Web of Science ®Google Scholar
• Zittoun R., Bernadou A., James J. M., Soria J., Bousser J. Acute myelo‐monocytic leukaemia: a terminal complication of paroxysmal nocturnal haemolobinuria. Acta Haematologica 1975; 53: 241–248
   PubMed Web of Science ®Google Scholar
• Munteanu N., Ursea C. Chronic refractory anemia with manifestations of paroxysmal nocturnal hemoglobinuria and chronic disseminated coagulopathy preceding the onset of acute myelomonocytic leukemia. Revista de Medicina Interna, Neurologie, Psichiatrie, Neurochirurgie, Dermato‐Venerologie. Seria: Medicina Internet 1988; 40: 89–94
   Google Scholar
• Lewis S. M., Pettit J. E., Tattersall M. H., Pepys M. B. Myelosclerosis and paroxysmal nocturnal haemoglobinuria. Scandinavian Journal of Haematology 1971; 8: 451–460
   PubMedGoogle Scholar
• Hirsch V. J., Neubach P. A., Parker D. M., Reese M. H., Stone M. J. Paroxysmal nocturnal hemoglobinuria. Termination in acute myelomonocytic leukemia and reappearance with leukemic remission. Archives of Internal Medicine 1981; 141: 525–527
   PubMed Web of Science ®Google Scholar
• Kere J., Knuwtila S., Runtu T., Leskinen R., de la Chapello A. Monocytic involvement by monosomy 7 preceded acute myelomonocytic leukemia in a patient with myelodysplastic syndrome. Leukemia 1988; 2: 69–73
   PubMed Web of Science ®Google Scholar
• Kuo C., Van Voolen G. A., Morrison A. N. Primary and secondary myelofibrosis: its relationship to “PNH‐like defect”. Blood 1972; 40: 875–880
   PubMed Web of Science ®Google Scholar
• Hirai H., Asahar A., Suzuki R. A case of myelofibrosis with paroxysmal nocturnal hemoglobinuria Rinsho Ketsueki. Japanese Journal of Clinical Hematology 1973; 14: 805–811
   PubMedGoogle Scholar
• van Kamp H., Smit J. W., van den Berg E., Ruud Halie M., Vellenga E. Myelodysplasia following paroxysmal nocturnal haemoglobinuria: evidence for the emergence of a separate clone. British Journal of Haematology 1994; 87: 399–400
   PubMed Web of Science ®Google Scholar
• Almquist A., Holm J., Wahlin A. Response to busulphan treatment of paroxysmal nocturnal hemoglobinuria and myelofibrosis in one and the same patient. Acta Medica Scandinavica 1981; 209: 133–135
   PubMed Web of Science ®Google Scholar
• Jin J. ‐Y., Tooze J. A., Marsh J. C. W., Mathhey F., Gordon‐Smith E. Myelodysplasia following aplastic anaemia‐paroxysmal nocturnal haemoglobinuria syndrome after treatment with immuno‐suppression and G‐CSF: evidence for the emergence of a separate clone. British Journal of Haematology 1996; 94: 510–512
   PubMed Web of Science ®Google Scholar
• Rotoli B., Luzzato L. Paroxysmal nocturnal hemoglobinuria. Seminars in Hematology 1989; 26: 201–207
   PubMed Web of Science ®Google Scholar
• Sirchia G., Lewis S. M. Paroxysmal nocturnal haemoglobinuria. Clinics in Haematology 1975; 4: 199–229
   PubMedGoogle Scholar
• Parker S. L., Tong T., Bolden S., Wingo P. A. Cancer statistics, 1996. CA: A Cancer Journal for Clinicians 1996; 46: 5–27
   PubMed Web of Science ®Google Scholar
• Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A., Gralnick H. R., Sultan C., The French‐American‐British (FAB) Co‐Operative Group. Proposals for the classification of the myelodysplastic syndromes. British Journal of Haematology 1982; 51: 189–199
   PubMed Web of Science ®Google Scholar
• Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Gallon D. A., Gralnick H. R., Sultan C. Proposal for the recognition of minimally differentiated acute myeloid leukemia (AML‐MO). British Journal of Haematology 1991; 78: 325–329
   PubMed Web of Science ®Google Scholar
• Turner A. R., Melynic A., Clark G. Time for a new acule myeloid classification?. British Journal of Haematology 1996; 92: 247–249
   PubMed Web of Science ®Google Scholar
• Berliner G. B., Ostroverkhii I. Myelocarcinosis as a cause of development of symptomatic form of paroxysmal nocturnal hemoglobinuria (PNH). Terapevticheskii Arkhiv 1978; 50: 112–113
   PubMed Web of Science ®Google Scholar
• Catovsky D., Lewis S. M., Sherman D. Erythrocyte sensitivity to in‐vitro lysis in leukaemia. British Journal of Haematology 1971; 21: 541–550
   PubMed Web of Science ®Google Scholar
• Polli E., Sirchia G., Ferrone S., Mercuriali F., Zanella A. Emoglobinuria parossistice noturna‐revisione critica. Edizioni. Cilig‐Chemie Italiana, Milano 1973
   Google Scholar
• Ko W. S., Chen L. M., Chao T. Y., Hwang W. S. Myeloblastic leukemoid reaction in paroxysmal nocturnal hemoglobinuria associated with myelodysplasia. Acta Haematologica 1992; 87: 75–77
   PubMed Web of Science ®Google Scholar
• Boyd A. W., Parkin J. D., Castaldi P. A. A case of paroxysmal nocturnal haemoglobinuria terminating in a myeloproliferative syndrome. Australian and New Zealand Journal of Medicine 1979; 9: 181–183
   PubMedGoogle Scholar
• Rosse W. F. Variations in the red cells in paroxysmal nocturnal haemoglobinuria. British Journal of Haematology 1973; 24: 327–342
   PubMed Web of Science ®Google Scholar
• Tichelli A., Gratwohl A., Nissen C., Speck B. Late clonal complications in severe aplastic anemia. Leukemia and Lymphoma 1994; 12: 167–175
   PubMed Web of Science ®Google Scholar
• Trichopoulos D., Lipworth L., Petridou E., Adami H. ‐O. Epidemiology of cancer. Cancer: Principles & Practice of Oncology, V. T. DeVita, Jr., S. Hellman, S. A. Rosenberg. Lippencott‐Raven, J. Philadelphia 1997; 231–25
   Google Scholar
• Dunn P. L.‐Y. S., Liaw S. ‐J. Paroxysmal nocturnal hemoglobinuria: Analysis of 40 cases. Journal of the Formosan Medical Association 1991; 90: 831–839
   PubMedGoogle Scholar
• Kruatrachue M., Wasi P., Na‐Nakom S. Paroxysmal nocturnal hemoglobinuria in Thailand with special reference to association with aplastic anemia. British Journal of Haematology 1978; 39: 267–276
   PubMed Web of Science ®Google Scholar
• Le X. Characteristics of paroxysmal nocturnal hemoglobinuria in China. Clinical analysis of 476 cases. Chinese Medical Journal 1990; 103: 885–889
   PubMed Web of Science ®Google Scholar
• Späth‐Schwalbe E., Schrezenmeier H., Heimpel H. Paroxsmale nätliche hämoglobinuria: Klinische erfahrargen bei 40 patienten in einem zentrum über 25 jahre. Deutsche Medizinische Wochenschrift 1995; 120: 1027–1033
   PubMed Web of Science ®Google Scholar
• Yang T. Y., Yang X. Y., Zhu X. Q., Kong X. Y. Clinical study on 94 cases of paroxysmal nocturnal hemoglobinuria. Chinese Journal of Internal Medicine 1965; 10: 866–868
   Google Scholar
• Van Voolen G. A., Hellstrom H. R., Nelson D. A. Paroxysmal nocturnal hemoglobinuria and the myeloproliferative syndrome. Annals of Internal Medicine 1982; 96: 792
   PubMed Web of Science ®Google Scholar
• Ware R. E., Marcus S. J., Gourley I. S., Seldin M. F., Howard T. A. Analysis of genetic instability in patients with paroxysmal nocturnal hemoglobinuria. Blood 1995; 86S: 131a
   Google Scholar
• Eshleman J. R., Markowitz S. D., Donover P. S., Lang E. Z., Lutterbaugh J. D., Li G. M., Longley M., Modrich P., Veigl M. L., Sedwick W. D. Diverse hypermutability of multiple expressed sequence motifs present in a cancer with microsatellite instability. Oncogene 1996; 12: 1425–1432
   PubMed Web of Science ®Google Scholar
• Burkhart‐Schultz K. J., Thompson C. L., Jones I. M. Spectrum of somatic mutations at the hypoxanthine phosphoribosyltransferase (hprt) gene of healthy people. Carcinogenogensis 1996; 17: 1871–1883
   PubMed Web of Science ®Google Scholar
• Becker J., Schwaab R., Moller‐Taube A., Schwaab U., Schmidt W., Brachmann H. H., Grimm T., Olek K., Oldenburg J. Characterization of the Factor VIII defect in 147 patients with sporadic hemophilia A: Family studies indicate a mutation type‐dependent sex ratio of mutation frequencies. American Journal of Human Genetics 1996; 58: 657–670
   PubMed Web of Science ®Google Scholar
• Vihinen M., Iwata T., Kinnon C., Kwan S. P., Ochs H. D., Vorechovsky I., Smith C. I. E. BTKbase, mutation database for X‐linked agammaglobulinemia (XLA). Nucleic Acids Research 1996; 24: 160–165
   PubMed Web of Science ®Google Scholar
• Livingstone L. R., White A., Sprouse J., Livanos E., Jacks T., Tlsty T. D. Altered cell cycle arrest and gene amplification potential accompany loss of wild‐type p53. Cell 1992; 70: 923–935
   PubMed Web of Science ®Google Scholar
• Harris C., Hollstein M. Clinical implications of the p53 tumor‐suppressor gene. New England Journal of Medicine 1993; 329: 1318–1327
   PubMed Web of Science ®Google Scholar
• Kuriya S., Dan K., Nomura T. Cytogenetic studies of paroxysmal nocturnal haemoglobinuria. Acta Haematologica Japonica 1981; 44: 839–844
   Web of Science ®Google Scholar
• Bottura C., Ferrari I. Etudes chromosomiques dans quelques anemies hemolytiques. Acta Haematologica 1962; 28: 20–24
   PubMed Web of Science ®Google Scholar
• Gol K. O., Swisher S. N. Chromosomal studies in patients with chronic myelocytic leukemia and myeloid metaplasia. Clinical Research 1963; 11: 194
   Google Scholar
• Beutler E., Goldenburg E. W., Ohio S., Yettra M. Chromosome 21 and paroxysmal nocturnal hemoglobinuria. Blood 1964; 24: 160–163
   PubMed Web of Science ®Google Scholar
• Ross J. D., Rosenbaum E. Paroxysmal nocturnal hemoglobinuria presenting as aplastic anemia in a child. Case report with evidence of deficient leukocyte acetylcholinesterase activity. American Journal of Medicine 1964; 37: 130–139
   PubMed Web of Science ®Google Scholar
• Hartmann R. C., Jenkins D. E., Jr. Paroxysmal nocturnal hemoglobinuria: Current concepts of certain pathophysiologic features. Blood 1965; 28: 850–865
   Google Scholar
• Fleischmann T., Bodor F. Aneuploidy in paroxysmal nocturnal haemoglobinuria. Acta Haematologica 1970; 44: 251–253
   PubMed Web of Science ®Google Scholar
• Zaccaria A., Ricci P., Baccarani M., Tura S. Chromosome studies in paroxysmal nocturnal haemoglobinuria. Acta Haematologica 1973; 50: 350–356
   PubMed Web of Science ®Google Scholar
• Ricci P., Emiliani E., Zaccaria A., Staffa C., Tura S. Contributo allo studio citogenetico della emoglobinuria parossitica nocturna (EPN). Haematologica 1973; 58: 163–168
   PubMedGoogle Scholar
• Whang‐Peng J., Knutsen T., Lee E. C., Leventhal B. Acquired XO/XY clones in bone marrow of a patient with paroxysmal nocturnal hemoglobinuria (PNH). Blood 1976; 47: 611–619
   PubMed Web of Science ®Google Scholar
• Kamada M., Uchino H. Preleukemic states in atom bomb survivors in Japan. Blood Cells 1976; 2: 57–65
   Google Scholar
• Cohen A. M., Shabtai F., Lewinski U., Klein B., Djaldetti M. Two abnormal clones in the bone marrow cells of a patient with paroxysmal nocturnal hemoglobinuria. Clinical Genetics 1979; 16: 178–182
   PubMed Web of Science ®Google Scholar
• Ruiz‐Arguelles G. J., Morales‐Aceves R., Labardini J. R., Kraus‐Weisman A. Paroxysmal nocturnal hemoglobinuria. Thirty‐year experience in the National Institute of Nutrition (Mexico). Sangre 1980; 26: 463–470
   Google Scholar
• Zaccaria A., Rosti G., Betti S., Testoni N., Baccarani M. Normal karyotype in seven patients with paroxysmal nocturnal haemoglobinuria. British Journal of Haematology 1982; 51: 333–334
   PubMed Web of Science ®Google Scholar
• Emilia G., Carci G., Sacchi S., Bolognesi I., Torelli G. Chromosomes in paroxysmal nocturnal haemoglobinuria. British Journal of Haematology 1983; 52: 338–339
   Web of Science ®Google Scholar
• Zaccaria A., Barbieri D., Castoldi G. L., Farraresi P., Finelli C., Hossfeld D. K., Milelman F., Rosti G., Testoni N., Van Den Berghe H. Normal bone marrow karyotype in paroxysmal nocturnal hemoglobinuria—a cooperative European study. Cancer Genetics and Cytogenetics 1983; 9: 211–215
   PubMed Web of Science ®Google Scholar
• Kawahara K., Witherspoon R. P., Storb R. Marrow transplantation for paroxysmal nocturnal hemoglobinuria. American Journal of Hematology 1992; 39: 283–288
   PubMed Web of Science ®Google Scholar
• Nakao S., Yamaguchi M., Takamatsu H., Shiobara S., Matusda T. Expansion of a paroxysmal nocturnal hemoglobinuria (PNH) clone after cyclosporine therapy for aplastic anemia/PNH syndrome. Blood 1992; 80: 2943–2944
   PubMed Web of Science ®Google Scholar
• Nakakuma H., Nagakura S., Horikawa K., Hidaka M., Kawaguchi T., Iwamoto N., Sanada J., Kagimoto T., Takatsuki K. Interleukin‐2‐dependent T‐cell lines established from paroxysmal nocturnal hemoglobinuria patients. Blood 1994; 84: 309–314
   PubMed Web of Science ®Google Scholar
• Narayanan M. N., Geary C. G., Freemont A. J., Kendra J. R. Long term follow‐up of aplastic anaemia. British Journal of Haematology 1994; 86: 837–843
   PubMed Web of Science ®Google Scholar
• Griscelli‐Bennaceur A., Gluckman E., Scroboahaci M. L., Jonveaux P., Vu T., Bazarbachi A., Carosella E. D., Sigaux F., Socié G. Aplastic anemia and paroxysmal nocturnal hemoglobinuria: search for a pathogenetic link. Blood 1995; 85: 1354–1363
   PubMed Web of Science ®Google Scholar
• Viniou N., Michali E., Meletis J., Andreopoulos A., Vaiopoulos G., Stavroyianni N., Loukopoulos D., Yataganas X. Trisomy 8 in a patient who responded to therapy with all‐trans‐retinoic acid and developed paroxysmal nocturnal haemoglobinuria. British Journal of Haematology 1997; 97: 135–136
   PubMed Web of Science ®Google Scholar
• Kudou H., Nagasawa T., Yoda T., Sakurai T., Kawada K., Onozawa K., Nakajima T., Kashiwagi H., Nomura T. A case of fatal PNH with erythroleukemia Rinsho Ketsueki. Japanese Journal of Clinical Hematology 1974; 15: 1066
   Google Scholar
• Young N. S. The problem of clonality in aplastic anemia: Dr. Dameshek's riddle, restated. Blood 1992; 79: 1385–1392
   PubMed Web of Science ®Google Scholar
• Brodsky R. A., Vala M. S., Barber J. P., Medof M. E., Jones R. Resistance to apoptosis caused by PIG‐A gene mutations in paroxysmal nocturnal hemoglobinuria. Proceedings of the National Academy of Sciences (USA) 1997; 94: 8756–8760
   PubMed Web of Science ®Google Scholar
• Horikawa K., Nakakuma H., Kawaguchi T., Iwamoto N., Nagakura S., Kagimoto T., Takatsuki K. Apoptosis resistance of blood cells from patients with paroxysmal nocturnal hemoglobinuria, aplastic anemia, and myelodysplastic syndrome. Blood 1997; 90: 2716–2722
   PubMed Web of Science ®Google Scholar
• Ware R. E., Nishimura J., Smith C., Rosse W. F., Howard T. A. Relative resistance to apoptosis in paroxysmal nocturnal hemoglobinuria is not affected by correction of GPI‐linked protein expression. Blood 1997; 90: 273a, abstr
   Google Scholar
• Flanagan J. G., Chan D. C., Leder P. Transmembrane form of the kit ligand growth factor is determined by alternative splicing and is missing in the Sld mutant. Cell 1991; 64: 1025–1035
   PubMed Web of Science ®Google Scholar
• Dunn D. E., Yu J., Nagarajan S., Devetten M., Weichold F. F., Medof M. E., Young N. S., Liu J. M. A knock‐out model of paroxysmal nocturnal hemoglobinuria: Pig‐a‐hematopoiesis is reconstituted following intercellular transfer of GPI‐anchored proteins. Proceedings of the National Academy of Sciences (USA) 1996; 93: 7938–7943
   PubMed Web of Science ®Google Scholar
• Hirose S., Ravi L., Hazra S. V., Medof M. E. Assembly and deacetylation of N‐acetylglucosaminyl‐plas‐manylinositol in normal and affected paroxysmal nocturnal hemoglobinuria cells. Proceedings of the National Academy of Sciences (USA) 1991; 88: 3762–3766
   PubMed Web of Science ®Google Scholar
• Vidugiriene J., Menon A. K. The GPI anchor of cell‐surface proteins is synthesized on the cytoplasmic face of the endoplasmic reticulum. Journal of Cell Biology 1994; 127: 333–341
   PubMed Web of Science ®Google Scholar
• Takahashi M., Inoue N., Ohishi K., Maeda Y., Nakamura N., Endo Y., Fujita T., Takeda J., Kinoshita T. PIG‐B, a membrane protein of the endoplasmic reticulum with a large lumenal domain, is involved in transferring the third mannose of the GPI anchor. EMBO Journal 1996; 15: 4254–4261
   PubMed Web of Science ®Google Scholar